Increased proportion of circulating matured B-cells recognizing PR3 in PR3-ANCA+ AAV (143), presence of ectopic lymphoid structures and autoreactive B-cells in inflamed tissue of GPA (144, 145) and glomerulonephritis (32) provide a rationale for targeting B-cells. The gene discussed is PRTN3; the disease is glomerulonephritis.